28 February, 2025 in Investor Relations Nexalin Technology Announces Initiation of Patient Recruitment for UCSD’s TBI & PTSD Clinical Study Following IRB Approval
26 February, 2025 in Investor Relations Nexalin Technology Welcomes General Wesley Clark to Military & Government Advisory Board
19 February, 2025 in Videos Inside Nexalin: CEO Mark White on TBI Solutions & Expanding Market Potential
10 February, 2025 in Investor Relations Nexalin Appointed as Industry Co-Chair of National TBI Registry Coalition
03 February, 2025 in Investor Relations Nexalin’s Breakthrough DIFS™ Neurostimulation Device Demonstrates Reduction in Blood Pressure while Enhancing Mental Health According to New Landmark Study
